Furthermore, while rapamycin treatment significantly decreased c-Myc levels in H460 cells, the difference in c-Myc expression in H292 cells was not statistically significant, suggesting potential variability in the response to mTOR inhibition among NSCLC cell lines. The gene discussed is MTOR; the disease is non-small cell lung carcinoma.